Capturing what matters: updating NICE methods guidance on measuring and valuing health.
Age-adjustment
Carer
Children
Health technology assessment
Health-related quality of life
Utilities
Journal
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
ISSN: 1573-2649
Titre abrégé: Qual Life Res
Pays: Netherlands
ID NLM: 9210257
Informations de publication
Date de publication:
Jul 2022
Jul 2022
Historique:
accepted:
30
01
2022
pubmed:
6
3
2022
medline:
15
6
2022
entrez:
5
3
2022
Statut:
ppublish
Résumé
In July 2019, the National Institute for Health and Care Excellence (NICE) initiated a major review of its health technology evaluation methods to update its methods guide. This update has recently concluded with the publication of its health technology evaluation manual in January 2022. This paper reports the methods and findings of the review in relation to the recommended approach to use for the measurement and valuation of health-related quality of life (HRQoL) in submissions to NICE. Issues related to (i) the methods to use when NICE's preferred measure (EQ-5D) is not appropriate or not available; (ii) adjusting health state utility values over time to account for age; (iii) measuring and valuing HRQoL in children and young people; and (iv) including carers' QoL in economic evaluations were included in this review. This commentary summarises the methods used to undertake the review, its findings, and the changes to NICE methods that were proposed based on these findings. It also outlines topics where further research is needed before definitive methods guidance can be issued. The broad proposals described here were subject to a public consultation in 2020 and a further consultation on the updated methods guidance was completed in October 2021 before the publication of the manual in January 2022.
Identifiants
pubmed: 35247152
doi: 10.1007/s11136-022-03101-6
pii: 10.1007/s11136-022-03101-6
pmc: PMC9188493
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2167-2173Informations de copyright
© 2022. The Author(s).
Références
Health Technol Assess. 2014 May;18(34):vii-viii, xiii-xxv, 1-188
pubmed: 24857402
J Rheumatol. 2017 Dec;44(12):1899-1903
pubmed: 28298567
Qual Life Res. 2013 Dec;22(10):2813-28
pubmed: 23709096
Value Health. 2011 Sep-Oct;14(6):907-20
pubmed: 21914513
Value Health. 2012 Jan;15(1):118-27
pubmed: 22264979
Value Health. 2012 Jul-Aug;15(5):708-15
pubmed: 22867780
Value Health. 2020 Jul;23(7):907-917
pubmed: 32762993
Pharmacoeconomics. 2019 Apr;37(4):451-456
pubmed: 30328563
Health Qual Life Outcomes. 2013 Mar 12;11:42
pubmed: 23497257
J Pers Disord. 2013 Jun;27(3):383-401
pubmed: 23445474
Value Health. 2011 Jun;14(4):539-45
pubmed: 21669378
Children (Basel). 2021 Aug 31;8(9):
pubmed: 34572196
J Clin Epidemiol. 2010 Jul;63(7):737-45
pubmed: 20494804
Qual Life Res. 2021 Aug;30(8):2197-2218
pubmed: 33818733
Value Health. 2011 Mar-Apr;14(2):390-9
pubmed: 21402307
Pharmacoeconomics. 2014 Aug;32(8):759-73
pubmed: 24846760
Pharmacoeconomics. 2015 Nov;33(11):1137-54
pubmed: 26040242
Value Health. 2019 Mar;22(3):267-275
pubmed: 30832964
Eur J Health Econ. 2018 May;19(4):557-570
pubmed: 28560520
Health Qual Life Outcomes. 2017 Nov 15;15(1):220
pubmed: 29141645
Value Health. 2021 Mar;24(3):443-460
pubmed: 33641779